Sangamo Therapeutics Announces Fourth Quarter and Full Year 2022 Conference Call and Webcast

Rhea-AI Summary

Sangamo Therapeutics (Nasdaq: SGMO) is set to host a conference call on February 22, 2023, at 4:30 p.m. ET to discuss its fourth quarter and full year 2022 financial results and business updates. Prior to this call, the company will release its financial results. Participants can register for the call using this link. An updated corporate presentation will also be available for review.

BRISBANE, Calif.--(BUSINESS WIRE)-- Sangamo Therapeutics, Inc. (Nasdaq: SGMO), a genomic medicine company, announced today that the company is scheduled to hold a conference call on Wednesday, February 22, 2023 at 4:30 p.m. ET to review its fourth quarter and full year 2022 financial results and business updates. Prior to the call, the company will have released its fourth quarter and full year financial results.

Participants should register for, and access, the call using this link. While not required, it is recommended to join 10 minutes prior to the event start. Once registered, participants will be given the option to either dial into the call with the number and unique passcode provided, or to use the dial-out option to connect their phone instantly. The link to access the live webcast can also be found on the Sangamo Therapeutics website in the Investors and Media section under Events.

An updated corporate presentation will be available in the Investors and Media section under Presentations.

A replay will be available following the conference call, accessible under Events.

About Sangamo Therapeutics

Sangamo Therapeutics is a clinical-stage biopharmaceutical company with a robust genomic medicines pipeline. Using ground-breaking science, including our proprietary zinc finger genome engineering technology and manufacturing expertise, Sangamo aims to create new genomic medicines for patients suffering from diseases for which existing treatment options are inadequate or currently don’t exist. To learn more, visit www.sangamo.com and connect with us on LinkedIn and Twitter.

View source version on businesswire.com: https://www.businesswire.com/news/home/20230221005175/en/

Investor & Media Inquiries

Louise Wilkie

ir@sangamo.com

media@sangamo.com

Source: Sangamo Therapeutics, Inc.

FAQ

When is Sangamo Therapeutics' conference call?

Sangamo Therapeutics' conference call is scheduled for February 22, 2023, at 4:30 p.m. ET.

What will be discussed in the February 22 conference call?

The conference call will review Sangamo Therapeutics' fourth quarter and full year 2022 financial results and business updates.

How can I attend Sangamo's conference call?

Participants can register for the call through a provided link in the press release.

Where can I find Sangamo Therapeutics' updated corporate presentation?

The updated corporate presentation will be available in the Investors and Media section on Sangamo's website.

Will there be a replay of the conference call?

Yes, a replay will be available following the conference call.